mitochondrial complex I deficiency
diseaseOn this page
Also known as complex 1 mitochondrial respiratory chain deficiencyisolated complex I deficiencyisolated mitochondrial respiratory chain complex I deficiencyisolated NADH-coenzyme Q reductase deficiencyisolated NADH-CoQ reductase deficiencyisolated NADH-ubiquinone reductase deficiencymitochondrial respiratory chain complex I deficiencyNADH coenzyme Q reductase deficiency
Summary
mitochondrial complex I deficiency (MONDO:0100133) is a disease with 38 cohort genes and 1 clinical trial. The dominant Reactome pathway is Complex I biogenesis (34 cohort genes). Top therapeutic interventions include elamipretide.
At a glance
- Prevalence: Unknown (Worldwide) [Orphanet-validated]
- Cohort genes: 38
- ClinVar variants: 202
- Phenotypes (HPO): 37
- Clinical trials: 1
Clinical features
Signs & symptoms
Clinical features (HPO)
37 HPO clinical features (Orphanet curated; top 37 by frequency):
| HPO ID | Term | Frequency |
|---|---|---|
| HP:0011923 | Decreased activity of mitochondrial complex I | Obligate (100%) |
| HP:0000114 | Proximal tubulopathy | Very frequent (80-99%) |
| HP:0000407 | Sensorineural hearing impairment | Very frequent (80-99%) |
| HP:0000486 | Strabismus | Very frequent (80-99%) |
| HP:0000508 | Ptosis | Very frequent (80-99%) |
| HP:0000543 | Optic disc pallor | Very frequent (80-99%) |
| HP:0000639 | Nystagmus | Very frequent (80-99%) |
| HP:0000817 | Reduced eye contact | Very frequent (80-99%) |
| HP:0001138 | Optic neuropathy | Very frequent (80-99%) |
| HP:0001251 | Ataxia | Very frequent (80-99%) |
| HP:0001252 | Hypotonia | Very frequent (80-99%) |
| HP:0001254 | Lethargy | Very frequent (80-99%) |
| HP:0001263 | Global developmental delay | Very frequent (80-99%) |
| HP:0001298 | Encephalopathy | Very frequent (80-99%) |
| HP:0001324 | Muscle weakness | Very frequent (80-99%) |
| HP:0001508 | Failure to thrive | Very frequent (80-99%) |
| HP:0001511 | Intrauterine growth retardation | Very frequent (80-99%) |
| HP:0001639 | Hypertrophic cardiomyopathy | Very frequent (80-99%) |
| HP:0001943 | Hypoglycemia | Very frequent (80-99%) |
| HP:0002013 | Vomiting | Very frequent (80-99%) |
| HP:0002093 | Respiratory insufficiency | Very frequent (80-99%) |
| HP:0002240 | Hepatomegaly | Very frequent (80-99%) |
| HP:0002352 | Leukoencephalopathy | Very frequent (80-99%) |
| HP:0002415 | Leukodystrophy | Very frequent (80-99%) |
| HP:0002421 | Poor head control | Very frequent (80-99%) |
| HP:0002490 | Increased CSF lactate | Very frequent (80-99%) |
| HP:0003128 | Lactic acidosis | Very frequent (80-99%) |
| HP:0003542 | Increased serum pyruvate | Very frequent (80-99%) |
| HP:0003737 | Mitochondrial myopathy | Very frequent (80-99%) |
| HP:0007704 | Paroxysmal involuntary eye movements | Very frequent (80-99%) |
| HP:0008316 | Abnormal mitochondria in muscle tissue | Very frequent (80-99%) |
| HP:0012748 | Focal T2 hyperintense brainstem lesion | Very frequent (80-99%) |
| HP:0000252 | Microcephaly | Occasional (5-29%) |
| HP:0000618 | Blindness | Occasional (5-29%) |
| HP:0000819 | Diabetes mellitus | Occasional (5-29%) |
| HP:0011968 | Feeding difficulties | Occasional (5-29%) |
| HP:0025116 | Fetal distress | Occasional (5-29%) |
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | mitochondrial complex I deficiency |
| Mondo ID | MONDO:0100133 |
| MeSH | C537475 |
| Orphanet | 2609 |
| DOID | DOID:0060536 |
| UMLS | C1838979 |
| MedGen | 374101 |
| GARD | 0003908 |
| Is cancer (heuristic) | no |
Also known as: complex 1 mitochondrial respiratory chain deficiency · isolated complex I deficiency · isolated mitochondrial respiratory chain complex I deficiency · isolated NADH-coenzyme Q reductase deficiency · isolated NADH-CoQ reductase deficiency · isolated NADH-ubiquinone reductase deficiency · mitochondrial respiratory chain complex I deficiency · NADH coenzyme Q reductase deficiency
Data availability: 202 ClinVar variants · 29 GenCC gene-disease records · 8 cell lines.
Disease family
An umbrella term covering 2 Mondo subtypes.
Classification path: disease › human disease › disease by developmental or physiological process › metabolic disease › developmental anomaly of metabolic origin › inborn mitochondrial metabolism disorder › mitochondrial oxidative phosphorylation disorder › mitochondrial respiratory chain complex deficiency › mitochondrial complex I deficiency
Related subtypes (8): mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, mitochondrial complex V (ATP synthase) deficiency, nuclear type 4B, mitochondrial complex III deficiency, mitochondrial complex V (ATP synthase) deficiency, nuclear type 5, mitochondrial complex IV deficiency, nuclear-type, SDHC-related Mitochondrial Disease
Subtypes (2): mitochondrial complex I deficiency, mitochondrial type, mitochondrial complex I deficiency, nuclear type
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
202 retrieved; paginated sample, class counts are floors:
55 uncertain significance, 46 pathogenic/likely pathogenic, 34 likely pathogenic, 30 conflicting classifications of pathogenicity, 21 likely benign, 6 benign/likely benign, 4 benign, 4 pathogenic, 2 not provided
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 7 | NM_025152.2(NUBPL):c.[166G>A;815-27T>C] | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | |
| 1414680 | NM_014049.5(ACAD9):c.1029+1dup | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1451120 | NM_014049.5(ACAD9):c.1240C>A (p.Arg414Ser) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2065147 | NM_014049.5(ACAD9):c.744_747del (p.Arg249fs) | ACAD9 | Pathogenic | criteria provided, multiple submitters, no conflicts |
| 242461 | NM_014049.5(ACAD9):c.1552C>T (p.Arg518Cys) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 242463 | NM_014049.5(ACAD9):c.1237G>A (p.Glu413Lys) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 242466 | NM_014049.5(ACAD9):c.796C>T (p.Arg266Trp) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 242524 | NM_014049.5(ACAD9):c.359del (p.Phe120fs) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 30880 | NM_014049.5(ACAD9):c.1249C>T (p.Arg417Cys) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 30883 | NM_014049.5(ACAD9):c.976G>C (p.Ala326Pro) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 30884 | NM_014049.5(ACAD9):c.1594C>T (p.Arg532Trp) | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 848539 | NM_014049.5(ACAD9):c.151-1_151del | ACAD9 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 95754 | NM_017547.4(FOXRED1):c.612_615dup (p.Ala206fs) | FOXRED1 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 14056 | NM_007103.4(NDUFV1):c.1268C>T (p.Thr423Met) | LOC126861242 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1982970 | NM_024120.5(NDUFAF5):c.24G>A (p.Trp8Ter) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1983600 | NM_024120.5(NDUFAF5):c.23G>A (p.Trp8Ter) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2073702 | NM_024120.5(NDUFAF5):c.46del (p.Ala16fs) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2121974 | NM_024120.5(NDUFAF5):c.42_54del (p.Trp15fs) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2138338 | NM_024120.5(NDUFAF5):c.29T>A (p.Leu10Ter) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2139992 | NM_024120.5(NDUFAF5):c.44G>A (p.Trp15Ter) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2676972 | NM_024120.5(NDUFAF5):c.30_31del (p.Cys11fs) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2889767 | NM_024120.5(NDUFAF5):c.174G>A (p.Trp58Ter) | LOC130065433 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 9712 | NC_012920.1(MT-ND3):m.10191T>C | MT-ND3 | Pathogenic | reviewed by expert panel |
| 790 | NM_014165.4(NDUFAF4):c.194T>C (p.Leu65Pro) | NDUFAF4 | Pathogenic | no assertion criteria provided |
| 1321429 | NM_024120.5(NDUFAF5):c.604C>T (p.Gln202Ter) | NDUFAF5 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1909379 | NM_024120.5(NDUFAF5):c.277_280del (p.Ala93fs) | NDUFAF5 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2078597 | NM_024120.5(NDUFAF5):c.183_190dup (p.Glu64fs) | NDUFAF5 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2141476 | NM_024120.5(NDUFAF5):c.204del (p.Phe68fs) | NDUFAF5 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2141503 | NM_024120.5(NDUFAF5):c.826C>T (p.Arg276Ter) | NDUFAF5 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 2154677 | NM_024120.5(NDUFAF5):c.408dup (p.Ser137fs) | NDUFAF5 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 137 · Orphanet: 47 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| FOXRED1 | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 19 | 7 |
| NDUFA1 | Definitive | X-linked | mitochondrial complex I deficiency, nuclear type 12 | 6 |
| NDUFB3 | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 25 | 5 |
| NDUFS1 | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 5 | 6 |
| NDUFS2 | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 6 | 9 |
| NDUFS7 | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 3 | 5 |
| NDUFS8 | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 2 | 5 |
| NDUFV1 | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 4 | 6 |
| NUBPL | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 21 | 4 |
| TMEM126B | Definitive | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 29 | 5 |
| NDUFA11 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 14 | 3 |
| NDUFA6 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 33 | 4 |
| NDUFAF1 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 11 | 4 |
| NDUFAF2 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 10 | 6 |
| NDUFAF3 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 18 | 5 |
| NDUFAF4 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 15 | 3 |
| NDUFAF5 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 16 | 5 |
| NDUFAF8 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 34 | 4 |
| NDUFB10 | Strong | Autosomal recessive | mitochondrial disease | 3 |
| NDUFS3 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 8 | 5 |
| NDUFS4 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 1 | 7 |
| NDUFS6 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 9 | 4 |
| NDUFV2 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 7 | 6 |
| TIMMDC1 | Strong | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 31 | 4 |
| NDUFB9 | Moderate | Autosomal recessive | mitochondrial complex I deficiency, nuclear type 24 | 4 |
| MT-ND1 | Supportive | Autosomal recessive | mitochondrial complex I deficiency | 5 |
| MT-ND2 | Supportive | Autosomal recessive | mitochondrial complex I deficiency | 3 |
| MT-ND3 | Supportive | Autosomal recessive | mitochondrial complex I deficiency | 3 |
| SLC35G2 | Limited | Autosomal recessive | mitochondrial complex I deficiency |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| NDUFAF5 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFAF1 | Orphanet:2609 | Isolated complex I deficiency |
| NUBPL | Orphanet:2609 | Isolated complex I deficiency |
| NDUFAF4 | Orphanet:2609 | Isolated complex I deficiency |
| FOXRED1 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFAF3 | Orphanet:2609 | Isolated complex I deficiency |
| TMEM126B | Orphanet:2609 | Isolated complex I deficiency |
| MT-ND1 | Orphanet:104 | Leber hereditary optic neuropathy |
| MT-ND1 | Orphanet:255210 | Mitochondrial DNA-associated Leigh syndrome |
| MT-ND1 | Orphanet:2609 | Isolated complex I deficiency |
| MT-ND1 | Orphanet:550 | MELAS |
| MT-ND2 | Orphanet:104 | Leber hereditary optic neuropathy |
| MT-ND2 | Orphanet:255210 | Mitochondrial DNA-associated Leigh syndrome |
| MT-ND2 | Orphanet:2609 | Isolated complex I deficiency |
| MT-ND3 | Orphanet:255210 | Mitochondrial DNA-associated Leigh syndrome |
| MT-ND3 | Orphanet:2609 | Isolated complex I deficiency |
| MT-ND3 | Orphanet:99718 | Leber plus disease |
| NDUFB10 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFB3 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFB9 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFS1 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFS2 | Orphanet:104 | Leber hereditary optic neuropathy |
| NDUFS2 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFS3 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFS4 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFS6 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFV1 | Orphanet:2609 | Isolated complex I deficiency |
| TIMMDC1 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFA11 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFAF2 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFAF8 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFA1 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFA6 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFS7 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFS8 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFV2 | Orphanet:139447 | Progressive cavitating leukoencephalopathy |
| NDUFV2 | Orphanet:2609 | Isolated complex I deficiency |
| NDUFA13 | Orphanet:146 | Differentiated thyroid carcinoma |
| NDUFB11 | Orphanet:2556 | Microphthalmia with linear skin defects syndrome |
| NDUFB11 | Orphanet:2609 | Isolated complex I deficiency |
| ACAD9 | Orphanet:99901 | Acyl-CoA dehydrogenase 9 deficiency |
| NDUFAF6 | Orphanet:3337 | Primary Fanconi renotubular syndrome |
| MT-ND4 | Orphanet:104 | Leber hereditary optic neuropathy |
| MT-ND4 | Orphanet:255210 | Mitochondrial DNA-associated Leigh syndrome |
| MT-ND4 | Orphanet:550 | MELAS |
| MT-ND4 | Orphanet:90641 | Rare mitochondrial non-syndromic sensorineural deafness |
| MT-ND4 | Orphanet:99718 | Leber plus disease |
Cohort genes → proteins
38 cohort genes, 37 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 38 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| NDUFAF5 | HGNC:15899 | ENSG00000101247 | Q5TEU4 | Arginine-hydroxylase NDUFAF5, mitochondrial | gencc,clinvar |
| NDUFAF1 | HGNC:18828 | ENSG00000137806 | Q9Y375 | Complex I intermediate-associated protein 30, mitochondrial | gencc,clinvar |
| NUBPL | HGNC:20278 | ENSG00000151413 | Q8TB37 | Iron-sulfur cluster transfer protein NUBPL | gencc,clinvar |
| NDUFAF4 | HGNC:21034 | ENSG00000123545 | Q9P032 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 | gencc,clinvar |
| FOXRED1 | HGNC:26927 | ENSG00000110074 | Q96CU9 | FAD-dependent oxidoreductase domain-containing protein 1 | gencc,clinvar |
| NDUFAF3 | HGNC:29918 | ENSG00000178057 | Q9BU61 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 | gencc,clinvar |
| TMEM126B | HGNC:30883 | ENSG00000171204 | Q8IUX1 | Complex I assembly factor TMEM126B, mitochondrial | gencc,clinvar |
| MT-ND1 | HGNC:7455 | ENSG00000198888 | P03886 | NADH-ubiquinone oxidoreductase chain 1 | gencc,clinvar |
| MT-ND2 | HGNC:7456 | ENSG00000198763 | P03891 | NADH-ubiquinone oxidoreductase chain 2 | gencc,clinvar |
| MT-ND3 | HGNC:7458 | ENSG00000198840 | P03897 | NADH-ubiquinone oxidoreductase chain 3 | gencc,clinvar |
| NDUFB10 | HGNC:7696 | ENSG00000140990 | O96000 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 | gencc,clinvar |
| NDUFB3 | HGNC:7698 | ENSG00000119013 | O43676 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 | gencc,clinvar |
| NDUFB9 | HGNC:7704 | ENSG00000147684 | Q9Y6M9 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 | gencc,clinvar |
| NDUFS1 | HGNC:7707 | ENSG00000023228 | P28331 | NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial | gencc,clinvar |
| NDUFS2 | HGNC:7708 | ENSG00000158864 | O75306 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial | gencc,clinvar |
| NDUFS3 | HGNC:7710 | ENSG00000213619 | O75489 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial | gencc,clinvar |
| NDUFS4 | HGNC:7711 | ENSG00000164258 | O43181 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial | gencc,clinvar |
| NDUFS6 | HGNC:7713 | ENSG00000145494 | O75380 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial | gencc,clinvar |
| NDUFV1 | HGNC:7716 | ENSG00000167792 | P49821 | NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | gencc,clinvar |
| TIMMDC1 | HGNC:1321 | ENSG00000113845 | Q9NPL8 | Complex I assembly factor TIMMDC1, mitochondrial | gencc |
| NDUFA11 | HGNC:20371 | ENSG00000174886 | Q86Y39 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 | gencc |
| NDUFAF2 | HGNC:28086 | ENSG00000164182 | Q8N183 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 | gencc |
| SLC35G2 | HGNC:28480 | ENSG00000168917 | Q8TBE7 | Solute carrier family 35 member G2 | gencc |
| NDUFAF8 | HGNC:33551 | ENSG00000224877 | A1L188 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8 | gencc |
| NDUFA1 | HGNC:7683 | ENSG00000125356 | O15239 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | gencc |
| NDUFA6 | HGNC:7690 | ENSG00000184983 | P56556 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 | gencc |
| NDUFS7 | HGNC:7714 | ENSG00000115286 | O75251 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial | gencc |
| NDUFS8 | HGNC:7715 | ENSG00000110717 | O00217 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial | gencc |
| NDUFV2 | HGNC:7717 | ENSG00000178127 | P19404 | NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | gencc |
| SLC25A10 | HGNC:10980 | ENSG00000183048 | Q9UBX3 | Mitochondrial dicarboxylate carrier | clinvar |
| MRPL36 | HGNC:14490 | ENSG00000171421 | Q9P0J6 | Large ribosomal subunit protein bL36m | clinvar |
| NDUFA13 | HGNC:17194 | ENSG00000186010 | Q9P0J0 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | clinvar |
| NDUFB11 | HGNC:20372 | ENSG00000147123 | Q9NX14 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial | clinvar |
| ACAD9 | HGNC:21497 | ENSG00000177646 | Q9H845 | Complex I assembly factor ACAD9, mitochondrial | clinvar |
| NDUFAF6 | HGNC:28625 | ENSG00000156170 | Q330K2 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 | clinvar |
| NDUFAF7 | HGNC:28816 | ENSG00000003509 | Q7L592 | Protein arginine methyltransferase NDUFAF7, mitochondrial | clinvar |
| C1QTNF3-AMACR | HGNC:49198 | ENSG00000273294 | C1QTNF3-AMACR readthrough (NMD candidate) | clinvar | |
| MT-ND4 | HGNC:7459 | ENSG00000198886 | C0HME5 | Mitochondrial alternative ND4 protein | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| NDUFAF5 | Arginine-hydroxylase NDUFAF5, mitochondrial | Arginine hydroxylase that mediates hydroxylation of ‘Arg-111’ of NDUFS7 and is involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1) at early stages. |
| NDUFAF1 | Complex I intermediate-associated protein 30, mitochondrial | As part of the MCIA complex, involved in the assembly of the mitochondrial complex I. |
| NUBPL | Iron-sulfur cluster transfer protein NUBPL | Iron-sulfur cluster transfer protein involved in the assembly of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). |
| NDUFAF4 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 | Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). |
| FOXRED1 | FAD-dependent oxidoreductase domain-containing protein 1 | Required for the assembly of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). |
| NDUFAF3 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 | Essential factor for the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). |
| TMEM126B | Complex I assembly factor TMEM126B, mitochondrial | As part of the MCIA complex, involved in the assembly of the mitochondrial complex I. |
| MT-ND1 | NADH-ubiquinone oxidoreductase chain 1 | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| MT-ND2 | NADH-ubiquinone oxidoreductase chain 2 | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| MT-ND3 | NADH-ubiquinone oxidoreductase chain 3 | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| NDUFB10 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 | Accessory subunit that is involved in the functional assembly of the mitochondrial respiratory chain complex I. |
| NDUFB3 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| NDUFB9 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. |
| NDUFS1 | NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| NDUFS2 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| NDUFS3 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| NDUFS4 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| NDUFS6 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| NDUFV1 | NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| TIMMDC1 | Complex I assembly factor TIMMDC1, mitochondrial | Chaperone protein involved in the assembly of the mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). |
| NDUFA11 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| NDUFAF2 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2 | Acts as a molecular chaperone for mitochondrial complex I assembly. |
| NDUFAF8 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8 | Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I, MT-ND1). |
| NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| NDUFA6 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed to be not involved in catalysis. |
| NDUFS7 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| NDUFS8 | NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| NDUFV2 | NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial | Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor. |
| SLC25A10 | Mitochondrial dicarboxylate carrier | Catalyzes the electroneutral exchange or flux of physiologically important metabolites such as dicarboxylates (malonate, malate, succinate), inorganic sulfur-containing anions, and phosphate, across the mitochondrial inner membrane. |
| NDUFA13 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| NDUFB11 | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial | Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. |
| ACAD9 | Complex I assembly factor ACAD9, mitochondrial | Together with NDUFAF1 and ECSIT, forms part of the mitochondrial complex I (MCIA),which is required for the biogenesis of respiratory Complex I (CI) and is therefore crucial for the activation of the oxidative phosphorylation system. |
| NDUFAF6 | NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 | Involved in the assembly of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I) at early stages. |
| NDUFAF7 | Protein arginine methyltransferase NDUFAF7, mitochondrial | Arginine methyltransferase involved in the assembly or stability of mitochondrial NADH:ubiquinone oxidoreductase complex (complex I). |
| MT-ND4 | Mitochondrial alternative ND4 protein | Regulates mitochondrial respiration by decreasing oxygen consumption. |
Protein-family classification
Druggable: 1 · Difficult: 1 · Unknown: 36 · Druggable fraction: 0.03
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Other/Unknown | 36 | 1.7× | 3e-07 |
| Transporter | 1 | 2.0× | 0.583 |
| Transcription factor | 1 | 0.2× | 0.993 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| NDUFAF5 | Other/Unknown | no | Methyltransf_11, SAM-dependent_MTases_sf, Malonyl-ACP_OMT | |
| NDUFAF1 | Other/Unknown | no | Galactose-bd-like_sf, NADH-UbQ_OxRdtase-assoc_prot30, NDUFAF1 | |
| NUBPL | Other/Unknown | no | Mrp-like_CS, Mrp/NBP35_ATP-bd, P-loop_NTPase | |
| NDUFAF4 | Other/Unknown | no | NDUFAF4 | |
| FOXRED1 | Other/Unknown | no | FAD-dep_OxRdtase, FAD/NAD-bd_sf | |
| NDUFAF3 | Other/Unknown | no | NDUFAF3/AAMDC, NDUF3, MTH938-like_sf | |
| TMEM126B | Other/Unknown | no | TMEM126 | |
| MT-ND1 | Other/Unknown | no | NADH_UbQ_OxRdtase_su1/FPO, NADH_UbQ_OxRdtase_su1_CS | |
| MT-ND2 | Other/Unknown | no | ND/Mrp_TM, NADH_UbQ_OxRdtase_chain2, NADH_DH_su2_C | |
| MT-ND3 | Other/Unknown | no | NADH_UbQ/plastoQ_OxRdtase_su3, NDAH_ubi_oxred_su3_sf | |
| NDUFB10 | Other/Unknown | no | NADH_UbQ_OxRdtase_su10, NDUFB10 | |
| NDUFB3 | Other/Unknown | no | NDUFB3 | |
| NDUFB9 | Other/Unknown | no | Complex1_LYR_dom, NDUFB9, Complex1_LYR_NDUFB9_LYRM3 | |
| NDUFS1 | Other/Unknown | no | NADH_UbQ_OxRdtase_75kDa_su_CS, 2Fe-2S_ferredoxin-type, Mopterin_OxRdtase | |
| NDUFS2 | Other/Unknown | no | NADH_Q_OxRdtase_suD, NADH_UbQ_OxRdtase_49kDa_CS, NDH1_su_D/H | |
| NDUFS3 | Other/Unknown | no | NADH_UbQ_OxRdtase_30kDa_su, NADH_DH_suC, NADH_UbQ_OxRdtase_CS | |
| NDUFS4 | Other/Unknown | no | NADH_UbQ_FeS_4_mit-like, NDUFS4-like_sf | |
| NDUFS6 | Transcription factor | no | NDUFS6, Znf_CHCC | |
| NDUFV1 | Other/Unknown | no | NADH-UbQ_OxRdtase_51kDa_CS, NADH-UbQ_OxRdtase_suF, Nuo51_FMN-bd | |
| TIMMDC1 | Other/Unknown | no | TIMMDC1 | |
| NDUFA11 | Other/Unknown | no | NDUFA11 | |
| NDUFAF2 | Other/Unknown | no | NDUFA12, ComplexI_NDUFA12 | |
| SLC35G2 | Other/Unknown | no | EamA_dom, EmrE-like | |
| NDUFAF8 | Other/Unknown | no | NDUFAF8 | |
| NDUFA1 | Other/Unknown | no | NADH_Ub_cplx-1_asu_su-1 | |
| NDUFA6 | Other/Unknown | no | NADH_Ub_cplx-1_asu_su-6, Complex1_LYR_NDUFA6_LYRM6 | |
| NDUFS7 | Other/Unknown | no | NADH_UbQ_OxRdtase-like_20kDa, NADH_UQ_OxRdtase_20Kd_su | |
| NDUFS8 | Other/Unknown | no | NADH_quinone_OxRdtase_chainI, 4Fe4S_Fe-S-bd, 4Fe4S_Fe_S_CS | |
| NDUFV2 | Other/Unknown | no | NuoE-like, Thioredoxin-like_sf, NuoE_N | |
| SLC25A10 | Transporter | yes | MCP, MCP_transmembrane, MCP_dom_sf | |
| MRPL36 | Other/Unknown | no | Ribosomal_bL36, Ribosomal_bL36_sp, Mitoribosomal_bL36m | |
| NDUFA13 | Other/Unknown | no | GRIM-19 | |
| NDUFB11 | Other/Unknown | no | NADH_UbQ_OxRdtase_ESSS_su | |
| ACAD9 | Other/Unknown | no | Acyl-CoA_DH_CS, AcylCoA_DH/ox_M, AcylCo_DH/oxidase_C | |
| NDUFAF6 | Other/Unknown | no | Squ/phyt_synthse, Isoprenoid_synthase_dom_sf | |
| NDUFAF7 | Other/Unknown | no | NDUFAF7, SAM-dependent_MTases_sf, NDUFAF7_sf | |
| C1QTNF3-AMACR | Other/Unknown | no | ||
| MT-ND4 | Other/Unknown | no | NADH4_N, ND/Mrp_TM, NADH_UbQ_OxRdtase |
Expression context
Cohort genes with no expression data: 0.
37 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 38 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| apex of heart | 14 |
| gastrocnemius | 7 |
| left ventricle myocardium | 7 |
| hindlimb stylopod muscle | 6 |
| right atrium auricular region | 5 |
| heart left ventricle | 5 |
| cardiac muscle of right atrium | 4 |
| calcaneal tendon | 3 |
| adipose tissue | 3 |
| right uterine tube | 3 |
| right adrenal gland | 2 |
| adrenal tissue | 2 |
| right hemisphere of cerebellum | 2 |
| left testis | 2 |
| right testis | 2 |
| granulocyte | 2 |
| myocardium | 2 |
| mucosa of transverse colon | 2 |
| putamen | 2 |
| pancreatic ductal cell | 2 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| NDUFAF5 | 261 | ubiquitous | marker | apex of heart, right atrium auricular region, hindlimb stylopod muscle |
| NDUFAF1 | 281 | ubiquitous | marker | apex of heart, gastrocnemius, right adrenal gland |
| NUBPL | 267 | ubiquitous | marker | calcaneal tendon, adrenal tissue, skeletal muscle tissue of biceps brachii |
| NDUFAF4 | 286 | ubiquitous | marker | pons, lateral nuclear group of thalamus, heart right ventricle |
| FOXRED1 | 232 | ubiquitous | marker | right hemisphere of cerebellum, cerebellar hemisphere, cerebellar cortex |
| NDUFAF3 | 280 | ubiquitous | marker | left testis, right testis, apex of heart |
| TMEM126B | 283 | ubiquitous | marker | pigmented layer of retina, C1 segment of cervical spinal cord, islet of Langerhans |
| MT-ND1 | 134 | ubiquitous | marker | adipose tissue, gastrocnemius, frontal cortex |
| MT-ND2 | 134 | broad | marker | adipose tissue, right uterine tube, left uterine tube |
| MT-ND3 | 134 | ubiquitous | marker | granulocyte, adipose tissue, left lobe of thyroid gland |
| NDUFB10 | 255 | ubiquitous | marker | left ventricle myocardium, cardiac muscle of right atrium, myocardium |
| NDUFB3 | 297 | ubiquitous | marker | heart left ventricle, right atrium auricular region, apex of heart |
| NDUFB9 | 255 | ubiquitous | marker | left ventricle myocardium, cardiac muscle of right atrium, kidney epithelium |
| NDUFS1 | 142 | ubiquitous | marker | corpus callosum, skeletal muscle tissue, adrenal tissue |
| NDUFS2 | 292 | ubiquitous | marker | apex of heart, gastrocnemius, heart left ventricle |
| NDUFS3 | 140 | ubiquitous | marker | putamen, mucosa of transverse colon, apex of heart |
| NDUFS4 | 294 | ubiquitous | marker | calcaneal tendon, skeletal muscle tissue of rectus abdominis, hindlimb stylopod muscle |
| NDUFS6 | 295 | ubiquitous | marker | tendon of biceps brachii, apex of heart, right atrium auricular region |
| NDUFV1 | 292 | ubiquitous | marker | apex of heart, right hemisphere of cerebellum, metanephros cortex |
| TIMMDC1 | 259 | ubiquitous | marker | left ventricle myocardium, cardiac muscle of right atrium, myocardium |
| NDUFA11 | 260 | ubiquitous | marker | pancreatic ductal cell, cardiac muscle of right atrium, left ventricle myocardium |
| NDUFAF2 | 139 | ubiquitous | marker | calcaneal tendon, lower esophagus muscularis layer, gastrocnemius |
| SLC35G2 | 222 | ubiquitous | marker | sperm, cartilage tissue, secondary oocyte |
| NDUFAF8 | 253 | ubiquitous | marker | medial globus pallidus, putamen, globus pallidus |
| NDUFA1 | 294 | ubiquitous | marker | left ventricle myocardium, cardiac ventricle, heart left ventricle |
| NDUFA6 | 134 | ubiquitous | marker | hindlimb stylopod muscle, heart left ventricle, right atrium auricular region |
| NDUFS7 | 286 | ubiquitous | marker | hindlimb stylopod muscle, apex of heart, gastrocnemius |
| NDUFS8 | 294 | ubiquitous | marker | apex of heart, right adrenal gland, right adrenal gland cortex |
| NDUFV2 | 137 | ubiquitous | marker | apex of heart, gastrocnemius, hindlimb stylopod muscle |
| SLC25A10 | 133 | ubiquitous | marker | right lobe of liver, mucosa of transverse colon, liver |
Protein interactions among cohort
Intra-cohort edges: 272.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| NDUFS3 | 5,461 |
| NDUFS8 | 5,298 |
| NDUFS2 | 4,412 |
| NDUFV1 | 3,982 |
| NDUFV2 | 3,918 |
| NDUFS1 | 3,899 |
| NDUFS7 | 3,621 |
| ACAD9 | 3,600 |
| MT-ND1 | 3,537 |
| NDUFA13 | 3,268 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| ACAD9 | FOXRED1 | intact, string_interaction |
| ACAD9 | MT-ND2 | string_interaction |
| ACAD9 | NDUFA1 | string_interaction |
| ACAD9 | NDUFA13 | biogrid_interaction, intact |
| ACAD9 | NDUFAF1 | biogrid_interaction, intact, string_interaction |
| ACAD9 | NDUFAF3 | biogrid_interaction |
| ACAD9 | NDUFAF4 | biogrid_interaction, intact, string_interaction |
| ACAD9 | NDUFAF5 | intact, string_interaction |
| ACAD9 | NDUFAF6 | string_interaction |
| ACAD9 | NDUFAF7 | string_interaction |
| ACAD9 | NDUFS2 | biogrid_interaction |
| ACAD9 | NDUFS3 | biogrid_interaction, intact |
| ACAD9 | NDUFS7 | biogrid_interaction, intact |
| ACAD9 | NUBPL | string_interaction |
| ACAD9 | TIMMDC1 | biogrid_interaction, intact, string_interaction |
| ACAD9 | TMEM126B | biogrid_interaction, intact, string_interaction |
| FOXRED1 | NDUFAF1 | string_interaction |
| FOXRED1 | NDUFAF2 | string_interaction |
| FOXRED1 | NDUFAF3 | string_interaction |
| FOXRED1 | NDUFAF4 | string_interaction |
| FOXRED1 | NDUFAF5 | string_interaction |
| FOXRED1 | NDUFAF6 | string_interaction |
| FOXRED1 | NDUFAF7 | biogrid_interaction, string_interaction |
| FOXRED1 | NDUFAF8 | string_interaction |
| FOXRED1 | NDUFB10 | biogrid_interaction |
| FOXRED1 | NDUFS4 | string_interaction |
| FOXRED1 | NDUFS7 | string_interaction |
| FOXRED1 | NUBPL | string_interaction |
| FOXRED1 | TIMMDC1 | string_interaction |
| FOXRED1 | TMEM126B | string_interaction |
| MT-ND1 | MT-ND2 | string_interaction |
| MT-ND1 | MT-ND3 | string_interaction |
| MT-ND1 | NDUFA1 | string_interaction |
| MT-ND1 | NDUFA13 | intact |
| MT-ND1 | NDUFAF1 | intact, string_interaction |
| MT-ND1 | NDUFAF4 | string_interaction |
| MT-ND1 | NDUFB11 | string_interaction |
| MT-ND1 | NDUFS2 | string_interaction |
| MT-ND1 | NDUFS3 | biogrid_interaction, intact |
| MT-ND1 | NDUFS6 | intact |
| MT-ND1 | NDUFS7 | string_interaction |
| MT-ND1 | NDUFV2 | intact |
| MT-ND1 | TIMMDC1 | intact |
| MT-ND2 | MT-ND3 | string_interaction |
| MT-ND2 | NDUFA11 | intact |
| MT-ND2 | NDUFA6 | intact |
| MT-ND2 | NDUFB11 | intact |
| MT-ND2 | NDUFB3 | intact |
| MT-ND2 | NDUFS1 | string_interaction |
| MT-ND2 | NDUFS3 | intact |
Structural data
PDB: 23 · AlphaFold-only: 14 · No structure: 1
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| MRPL36 | Q9P0J6 | 73 |
| NDUFS2 | O75306 | 8 |
| NDUFA13 | Q9P0J0 | 8 |
| MT-ND2 | P03891 | 7 |
| NDUFB10 | O96000 | 7 |
| NDUFB3 | O43676 | 7 |
| NDUFB9 | Q9Y6M9 | 7 |
| NDUFS1 | P28331 | 7 |
| NDUFS3 | O75489 | 7 |
| NDUFS4 | O43181 | 7 |
| NDUFS6 | O75380 | 7 |
| NDUFV1 | P49821 | 7 |
| NDUFA11 | Q86Y39 | 7 |
| NDUFA1 | O15239 | 7 |
| NDUFA6 | P56556 | 7 |
| NDUFS7 | O75251 | 7 |
| NDUFS8 | O00217 | 7 |
| NDUFV2 | P19404 | 7 |
| NDUFB11 | Q9NX14 | 7 |
| MT-ND4 | C0HME5 | 7 |
| MT-ND1 | P03886 | 5 |
| MT-ND3 | P03897 | 5 |
| ACAD9 | Q9H845 | 2 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| NDUFAF8 | A1L188 | 91.12 |
| FOXRED1 | Q96CU9 | 90.12 |
| NDUFAF6 | Q330K2 | 87.70 |
| NDUFAF7 | Q7L592 | 85.54 |
| NDUFAF5 | Q5TEU4 | 85.43 |
| NUBPL | Q8TB37 | 85.40 |
| NDUFAF4 | Q9P032 | 83.37 |
| TMEM126B | Q8IUX1 | 82.06 |
| NDUFAF3 | Q9BU61 | 79.02 |
| NDUFAF2 | Q8N183 | 78.98 |
| SLC35G2 | Q8TBE7 | 77.60 |
| SLC25A10 | Q9UBX3 | 77.53 |
| NDUFAF1 | Q9Y375 | 73.37 |
| TIMMDC1 | Q9NPL8 | 72.08 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 19. Enrichment computed across 38 evidence-associated genes (36 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 36 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Complex I biogenesis | 34 | 156.3× | 2e-76 | NDUFAF5, NDUFAF1, NUBPL, NDUFAF4, FOXRED1, NDUFAF3, TMEM126B, MT-ND1 (+26 more) |
| Respiratory electron transport | 31 | 82.0× | 2e-57 | NDUFAF5, NDUFAF4, NDUFAF3, TMEM126B, MT-ND1, MT-ND2, MT-ND3, NDUFB10 (+23 more) |
| Aerobic respiration and respiratory electron transport | 27 | 66.4× | 8e-46 | NDUFAF5, NDUFAF4, NDUFAF3, TMEM126B, NDUFB10, NDUFB3, NDUFB9, NDUFS1 (+19 more) |
| Metabolism | 27 | 8.7× | 3e-21 | NDUFAF5, NDUFAF4, NDUFAF3, TMEM126B, NDUFB10, NDUFB3, NDUFB9, NDUFS1 (+19 more) |
| Mitochondrial protein degradation | 6 | 19.0× | 2e-06 | MT-ND1, MT-ND2, NDUFS1, NDUFS3, NDUFV1, NDUFA13 |
| Mitochondrial translation termination | 5 | 15.2× | 5e-05 | MT-ND1, MT-ND2, MT-ND3, MRPL36, MT-ND4 |
| Sulfide oxidation to sulfate | 1 | 52.9× | 0.051 | SLC25A10 |
| Organic anion transport by SLC5/17/25 transporters | 1 | 39.6× | 0.059 | SLC25A10 |
| Metabolism of proteins | 5 | 1.7× | 0.341 | NDUFS1, NDUFS3, NDUFV1, MRPL36, NDUFA13 |
| RHOG GTPase cycle | 1 | 4.1× | 0.347 | NDUFS3 |
| Mitochondrial translation | 1 | 3.8× | 0.347 | MRPL36 |
| Mitochondrial translation initiation | 1 | 3.5× | 0.347 | MRPL36 |
| Mitochondrial translation elongation | 1 | 3.5× | 0.347 | MRPL36 |
| Mitochondrial ribosome-associated quality control | 1 | 3.4× | 0.347 | MRPL36 |
| Translation | 1 | 1.7× | 0.539 | MRPL36 |
| RHO GTPase cycle | 1 | 1.7× | 0.539 | NDUFS3 |
| Signaling by Rho GTPases | 1 | 0.9× | 0.702 | NDUFS3 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 1 | 0.9× | 0.702 | NDUFS3 |
| Signal Transduction | 1 | 0.3× | 0.976 | NDUFS3 |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 36 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| mitochondrial respiratory chain complex I assembly | 25 | 285.4× | 2e-59 | NDUFAF5, NDUFAF1, NUBPL, NDUFAF4, FOXRED1, NDUFAF3, TMEM126B, MT-ND1 (+17 more) |
| mitochondrial electron transport, NADH to ubiquinone | 20 | 199.2× | 2e-42 | NDUFAF1, MT-ND1, MT-ND2, MT-ND3, NDUFB10, NDUFB3, NDUFB9, NDUFS1 (+12 more) |
| proton motive force-driven mitochondrial ATP synthesis | 21 | 153.6× | 5e-42 | MT-ND1, MT-ND2, MT-ND3, NDUFB10, NDUFB3, NDUFB9, NDUFS1, NDUFS2 (+13 more) |
| aerobic respiration | 21 | 144.6× | 2e-41 | MT-ND1, MT-ND2, MT-ND3, NDUFB10, NDUFB3, NDUFB9, NDUFS1, NDUFS2 (+13 more) |
| reactive oxygen species metabolic process | 4 | 52.0× | 1e-05 | MT-ND2, NDUFS3, NDUFS4, NDUFS6 |
| electron transport coupled proton transport | 2 | 234.1× | 3e-04 | MT-ND4, NDUFS7 |
| mitochondrial ATP synthesis coupled electron transport | 2 | 104.0× | 0.002 | NDUFS2, NDUFV1 |
| thiosulfate transport | 1 | 468.1× | 0.016 | SLC25A10 |
| peptidyl-arginine methylation, to symmetrical-dimethyl arginine | 1 | 468.1× | 0.016 | NDUFAF7 |
| malate transmembrane transport | 1 | 468.1× | 0.016 | SLC25A10 |
| oxaloacetate transport | 1 | 234.1× | 0.025 | SLC25A10 |
| mesenchymal stem cell differentiation | 1 | 234.1× | 0.025 | NDUFS6 |
| mesenchymal stem cell proliferation | 1 | 234.1× | 0.025 | NDUFS6 |
| dicarboxylic acid transport | 1 | 156.0× | 0.030 | SLC25A10 |
| obsolete sulfide oxidation, using sulfide:quinone oxidoreductase | 1 | 156.0× | 0.030 | SLC25A10 |
| response to hypoxia | 3 | 8.0× | 0.030 | MT-ND1, MT-ND2, MT-ND4 |
| glyceraldehyde-3-phosphate biosynthetic process | 1 | 117.0× | 0.034 | SLC25A10 |
| succinate transmembrane transport | 1 | 117.0× | 0.034 | SLC25A10 |
| cellular response to oxygen levels | 1 | 117.0× | 0.034 | NDUFS2 |
| gliogenesis | 1 | 78.0× | 0.046 | NDUFS2 |
| medium-chain fatty acid metabolic process | 1 | 78.0× | 0.046 | ACAD9 |
| reproductive system development | 1 | 66.9× | 0.051 | NDUFS6 |
| response to light intensity | 1 | 58.5× | 0.055 | MT-ND3 |
| stem cell division | 1 | 52.0× | 0.060 | NDUFS6 |
| response to hydroperoxide | 1 | 46.8× | 0.061 | MT-ND1 |
| negative regulation of insulin secretion involved in cellular response to glucose stimulus | 1 | 46.8× | 0.061 | NDUFAF2 |
| circulatory system development | 1 | 39.0× | 0.070 | NDUFS6 |
| protein insertion into mitochondrial inner membrane | 1 | 36.0× | 0.073 | NDUFA13 |
| phosphate ion transmembrane transport | 1 | 33.4× | 0.074 | SLC25A10 |
| sulfate transmembrane transport | 1 | 33.4× | 0.074 | SLC25A10 |
Therapeutics
Drug target analysis
Approved (phase 4): 0 · Phase ≥3: 1 · Phased (≥1): 1 · Undrugged: 37
Druggability breadth: 26 of 38 evidence-associated genes (68%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| NDUFA13 | 1 | 3 |
| NDUFAF5 | 0 | 0 |
| NDUFAF1 | 0 | 0 |
| NUBPL | 0 | 0 |
| NDUFAF4 | 0 | 0 |
| FOXRED1 | 0 | 0 |
| NDUFAF3 | 0 | 0 |
| TMEM126B | 0 | 0 |
| MT-ND1 | 0 | 0 |
| MT-ND2 | 0 | 0 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| ALISERTIB | 3 | NDUFA13 |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 0.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| NDUFS2 | 11 | Binding:10, Functional:1 |
| NDUFA13 | 6 | Binding:6 |
| NDUFAF4 | 5 | Binding:5 |
| MT-ND1 | 5 | Binding:5 |
| NDUFB10 | 5 | Binding:5 |
| NDUFB9 | 5 | Binding:5 |
| NDUFS1 | 5 | Binding:5 |
| NDUFS3 | 5 | Binding:5 |
| NDUFS6 | 5 | Binding:5 |
| NDUFV1 | 5 | Binding:5 |
| NDUFAF2 | 5 | Binding:5 |
| NDUFS7 | 5 | Binding:5 |
| NDUFV2 | 5 | Binding:5 |
| NDUFAF1 | 4 | Binding:4 |
| NDUFAF3 | 4 | Binding:4 |
| MT-ND2 | 4 | Binding:4 |
| MT-ND3 | 4 | Binding:4 |
| NDUFB3 | 4 | Binding:4 |
| NDUFS4 | 4 | Binding:4 |
| NDUFA11 | 4 | Binding:4 |
| NDUFA1 | 4 | Binding:4 |
| NDUFA6 | 4 | Binding:4 |
| NDUFS8 | 4 | Binding:4 |
| NDUFB11 | 4 | Binding:4 |
| ACAD9 | 1 | Binding:1 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 37; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
1 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| ALISERTIB | 3 | NDUFA13 |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 0 | |
| B | Phased (≥1) drug, not yet approved | 1 | NDUFA13 |
| C | Druggable family + PDB, no drug | 0 | |
| D | Druggable family + AlphaFold only, no drug | 1 | SLC25A10 |
| E | Difficult family or no structure, no drug | 36 | NDUFAF5, NDUFAF1, NUBPL, NDUFAF4, FOXRED1, NDUFAF3, TMEM126B, MT-ND1, MT-ND2, MT-ND3 (+26 more) |
Undrugged target profiles
37 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| NDUFAF5 | 0 | — |
| NDUFAF1 | 4 | — |
| NUBPL | 0 | — |
| NDUFAF4 | 5 | — |
| FOXRED1 | 0 | — |
| NDUFAF3 | 4 | — |
| TMEM126B | 0 | — |
| MT-ND1 | 5 | — |
| MT-ND2 | 4 | — |
| MT-ND3 | 4 | — |
| NDUFB10 | 5 | — |
| NDUFB3 | 4 | — |
| NDUFB9 | 5 | — |
| NDUFS1 | 5 | — |
| NDUFS2 | 11 | — |
| NDUFS3 | 5 | — |
| NDUFS4 | 4 | — |
| NDUFS6 | 5 | — |
| NDUFV1 | 5 | — |
| TIMMDC1 | 0 | — |
| NDUFA11 | 4 | — |
| NDUFAF2 | 5 | — |
| SLC35G2 | 0 | — |
| NDUFAF8 | 0 | — |
| NDUFA1 | 4 | — |
| NDUFA6 | 4 | — |
| NDUFS7 | 5 | — |
| NDUFS8 | 4 | — |
| NDUFV2 | 5 | — |
| SLC25A10 | 0 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 1.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| PHASE3 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT05162768 | PHASE3 | COMPLETED | Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) |
Drugs tested across these trials (top 30)
| Molecule | Max phase | Trials referencing |
|---|---|---|
| ELAMIPRETIDE | 3 | 1 |
Related Atlas pages
- Cohort genes: NDUFAF5, NDUFAF1, NUBPL, NDUFAF4, FOXRED1, NDUFAF3, TMEM126B, MT-ND1, MT-ND2, MT-ND3, NDUFB10, NDUFB3, NDUFB9, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFV1, TIMMDC1, NDUFA11, NDUFAF2, SLC35G2, NDUFAF8, NDUFA1, NDUFA6, NDUFS7, NDUFS8, NDUFV2, SLC25A10, MRPL36, NDUFA13, NDUFB11, ACAD9, NDUFAF6, NDUFAF7, MT-ND4
- Drugs: Elamipretide